Skip to main content
SpringerLink
Log in

Lack of effect of perindoprilat, an angiotensin-I converting enzyme inhibitor, during coronary artery occlusion and reperfusion in the anesthetized dog

  • Letter to the Editor
  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ribuot C, Rochette L. Converting enzyme inhibitors (captopril, enalapril, perindopril) prevent early-post infarction ventricular fibrillation in the anaesthetized rat. Cardiovasc Drugs Ther 1987;1:51–55.

    Google Scholar 

  2. Webster MWI, Fitzpatrick MA, Nicholls MG, et al. Effect of enalapril on ventricular arrhythmias in congestive heart failure. Am J Cardiol 1985;156:566–569.

    Google Scholar 

  3. Berdeaux A, Bonhenry C, Giudicelli JF. Effects of four angiotensin I converting enzyme inhibitors on regional myocardial blood flow and ischemic injury during coronary artery occlusion in dogs. Fundam Clin Pharmacol 1987;1:201–212.

    Google Scholar 

  4. Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals? Circulation 1988;77:I30-I39.

    Google Scholar 

  5. Elfellah M, Ogilvie RI. Effect of vasodilator drugs on coronary occlusion and reperfusion arrhythmias in anaesthetized dogs. J Cardiovasc Pharmacol 1985;7:826–832.

    Google Scholar 

  6. Daniell HB, Carson RR, Ballard KD, et al. Effects of captopril on limiting infarct size in conscious dogs. J Cardiovasc Pharmacol 1984;6:1043–1047.

    Google Scholar 

  7. Wesseling H, deGraeff PA, vanGilst WH, et al. Cardiac arrhythmias—a new indication for angiotensin-converting enzyme inhibitors? J Human Hypertens 1989;3:89–95.

    Google Scholar 

  8. Muller CA, Opie LH, Basset HM. Antiarrhythmic and hemodynamic effects of perindopril, a new angiotensin converting enzyme inhibitor, in pigs with coronary ligation. Cardiovasc Drugs Ther 1989;3(Suppl 2):613.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Faculty of Pharmacy, Université de Montréal, Canada

    Christophe Ribuot & Nobuharu Yamaguchi

  2. Faculty of Medicine, Université de Montréal, Canada

    Réginald Nadeau

  3. IRIS Compagnie & Développement, Courbevoie, France

    Michelle Devissaguet & Elizabeth Scalbert

  4. Laboratoire de Pharmacodynamie, Faculties of Medicine and Pharmacy, Dijon, France

    Luc Rochette

Authors
  1. Christophe Ribuot
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Réginald Nadeau
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobuharu Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michelle Devissaguet
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Elizabeth Scalbert
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luc Rochette
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ribuot, C., Nadeau, R., Yamaguchi, N. et al. Lack of effect of perindoprilat, an angiotensin-I converting enzyme inhibitor, during coronary artery occlusion and reperfusion in the anesthetized dog. Cardiovasc Drug Ther 5, 1047–1048 (1991). https://doi.org/10.1007/BF00143535

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00143535

Key Words

Search

Navigation